Prescription Anesthetic Drug Recalled for Subpotent Epinephrine Content
Fresenius Kabi is recalling Sensorcaine anesthetic injections nationwide due to subpotent epinephrine content. Affected batches may not provide adequate anesthesia or hemostasis during procedures.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall involving risk-of-harm product (subpotent local anesthetic may cause inadequate anesthesia or hemostasis) with no reported illnesses or injuries. Per rubric, risk-of-harm without reported injury scores as High (3).
Plain-English summary
Fresenius Kabi USA, LLC is recalling Sensorcaine (Bupivacaine HCl and Epinephrine Bitartrate Injection, USP) 0.5%, in 50 mL multiple-dose vials. The recall affects 40,025 vials distributed nationwide.
Testing results for the epinephrine component of the recalled product fell below the defined limit. This deficiency may result in inadequate hemostasis (blood clotting control) or insufficient duration of local anesthesia during medical procedures.
Healthcare providers should immediately quarantine and discontinue use of the affected batches: 6128399, 6128400, and 6128401 (expiration April 2024). Patients and providers should report any adverse events or concerns related to these batches to Fresenius Kabi or the FDA.
The recalled product
- Product
- SENSORCAINE (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE)
- Brand
- SENSORCAINE
- Manufacturer
- Fresenius Kabi USA, LLC
- Hazard
- subpotent-epinephrine
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Batch #: 6128399
- 6128400
- 6128401
- exp 04/2024
UPCs (6)
- 0363323472030
- 0363323461010
- 0363323463014
- 0363323468026
- 0363323472016
- 0363323468019
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SENSORCAINE
- HighInjectable Anesthetic Sensorcaine Recalled for Subpotent Epinephrine
FDA (Drugs) · 2023-01-25
- HighLocal anesthetic Sensorcaine vials recalled for subpotent epinephrine
FDA (Drugs) · 2023-01-25
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01